December 29, 2009
BD to Present at Investor Healthcare Conferences
|
December 08, 2009
BD Biosciences Announces First Winners of Expanded Research Grant Program
|
December 07, 2009
BD Expands Diagnostic Testing Offerings in Women's Health
|
November 24, 2009
BD Board Increases Dividend and Authorizes Additional Share Repurchases
|
November 19, 2009
BD Completes Acquisition of HandyLab, Inc.
|
November 05, 2009
BD Diagnostics Launches Turnkey Continuing Education Program for Clinical Laboratories
|
November 04, 2009
BD to Present at Investor Healthcare Conferences
|
November 04, 2009
BD Announces Results for Fourth Fiscal Quarter and Full Year
|
October 30, 2009
BD Director Emeritus Henry P. Becton, Sr. Dies at 95
|
October 23, 2009
BD Announces Agreement to Acquire HandyLab, Inc.
|
October 07, 2009
BD Ranked in the Top 100 Greenest Big Companies by Newsweek; Named Again to Dow Jones Sustainability World and North America Indexes
|
October 06, 2009
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
|
October 06, 2009
BD Announces FDA 510(k) Clearance of BD Vacutainer® Rapid Serum Blood Collection Tube
|
September 25, 2009
BD Receives Health Canada Approval for the BD FocalPoint™ GS Imaging System to Enhance the Detection of Cervical Cancer
|
September 14, 2009
BD Launches Expanded Line of BD Visitec™ Single-Use Microsurgical Instruments and Customized Trays
|
September 03, 2009
BD Announces Flu Product Order from U.S. Government
|
August 25, 2009
NBA Legend Dikembe Mutombo, UNICEF Executive Director Ann M. Veneman and BD Commemorate Opening of New Center to Improve HIV/AIDS Treatment in the DRC
|
August 12, 2009
BD Biosciences Expands Reagent and Dye Portfolio for Cellular Analysis
|
August 11, 2009
BD and PEPFAR Collaboration Will Improve Blood-drawing Practices in Hospitals and Clinics in Sub-Saharan Africa
|
August 06, 2009
BD Adds Surveillance Capability to Infectious Disease Portfolio
|
August 04, 2009
BD Biosciences Launches Laboratory Information System Interface Software for Labs Using BD Flow Cytometers
|
August 04, 2009
BD and Direct Relief International Team Up to Provide Free Diabetes Insulin Injection Products to Americans Impacted by the Economic Downturn
|
July 29, 2009
BD Announces Results for Third Fiscal Quarter
|
July 28, 2009
BD Board Declares Dividend
|
July 23, 2009
BD Flu Preparedness Statement
|
July 19, 2009
BD/PEPFAR Lab-Strengthening Initiative Marks Progress in Fight Against HIV/Aids and TB in Sub-Saharan Africa
|
July 09, 2009
New Flow Cytometry-based Methods for Stem Cell Research Presented at Annual International Society for Stem Cell Research Meeting
|
June 30, 2009
BD Biosciences Launches New Portfolio of Surfaces for Cell-Based Drug Discovery Screening and Basic Cell Culture Research
|
June 29, 2009
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
|
June 17, 2009
BD and FIND Achieve Milestone in Global Battle Against MDR-TB
|
June 01, 2009
BD Biosciences Launches New Cell Analyzer for Complex Multicolor Experiments in Disease and Drug Development Research
|
June 01, 2009
BD to Present at Investor Healthcare Conferences
|
May 20, 2009
BD Board Declares Dividend
|
May 18, 2009
BD and HandyLab Announce Exclusive Collaboration to Commercialize Molecular Assays
|
May 13, 2009
BD Biosciences Launches BD UltraPool™ HLM 150 Reagent
|
May 08, 2009
BD Extends Decade-Long Support for UNICEF's Campaign to Eliminate Maternal and Neonatal Tetanus
|
May 08, 2009
BD Biosciences Announces Winners of Annual Research Grant Program
|
May 08, 2009
BD Biosciences Expands Research Grant Program to Offer Researchers More Support During Tough Economic Times
|
May 04, 2009
BD and Fujirebio Diagnostics Sign Worldwide Agreement to Develop Biomarker Assays to Improve Cancer Detection and Management
|
April 28, 2009
BD Announces Results for Second Fiscal Quarter
|
April 01, 2009
American Red Cross of Northern New Jersey Honors BD and President Vince Forlenza during April's "Touch of Red" Virtual Fundraising Gala
|
April 01, 2009
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
|
March 23, 2009
BD Announces FDA 510(k) Clearance of BD ProbeTec™ Qx Amplified Assays for the Detection of Chlamydia trachomatis and Neisseria gonorrhoeae
|
March 17, 2009
BD Launches BD OcuSeal™ Liquid Ocular Bandage
|
March 12, 2009
BD Joins Safe Injection Practices Coalition
|
March 11, 2009
BD Named to 100 Best Corporate Citizens List by CRO Magazine
|
March 11, 2009
BD Biosciences Facility in San Jose, California Achieves LEED Silver Certification
|
February 26, 2009
BD Soluvia™ Microinjection System Used For First Approved Intradermal Influenza Vaccine in the European Union
|
February 23, 2009
BD Ranks 23rd on EPA's Fortune 500 List of Green Power Purchasers
|
February 10, 2009
BD Announces CE Marking of BD ProbeTec™ Qx Amplified Assays to Improve Detection of Chlamydia trachomatis and Neisseria gonorrhoeae
|
February 03, 2009
BD Board Declares Dividend
|
February 03, 2009
BD Announces Results of Shareholder Votes at Annual Meeting
|
January 28, 2009
BD Announces Results for First Fiscal Quarter
|
January 14, 2009
New BD BACTEC™ FX Blood Culture System with the BD EpiCenter™ Operating System now Available Worldwide
|
January 14, 2009
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
|
January 14, 2009
BD Announces Webcast of Annual Meeting of Shareholders
|
January 12, 2009
BD Announces FDA 510(k) Clearance of Novel Molecular Assay to Diagnose Clostridium difficile Infections
|
